Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Antiarrhythmic action of specific bradycardic agents.

Vaughan Williams EM.

Eur Heart J. 1987 Dec;8 Suppl L:17-18. No abstract available.

PMID:
3451879
2.

[Sinus node inhibitors in coronary surgery].

Gombotz H.

Herz. 1990 Oct;15(5):335-42. German.

PMID:
2227768
3.

Effects of specific bradycardic agents on exercise-induced regional myocardial dysfunction in dogs.

Raberger G, Krumpl G, Schneider W, Mayer N.

Eur Heart J. 1987 Dec;8 Suppl L:53-9.

PMID:
3451883
4.

Antiischemic and antiarrhythmic activities of some novel alinidine analogs in the rat heart.

Challinor-Rogers JL, Rosenfeldt FL, Du XJ, McPherson GA.

J Cardiovasc Pharmacol. 1997 Apr;29(4):499-507.

PMID:
9156360
5.

The actions and clinical use of the newer antiarrhythmic drugs.

Hayes AH Jr.

Ration Drug Ther. 1972 Jul;6(7):1-6. No abstract available.

PMID:
5085124
6.

The case for inpatient initiation of antiarrhythmic therapy.

Myerburg RJ, Kloosterman M, Yamamura K, Mitrani R, Interian A Jr, Castellanos A.

J Cardiovasc Electrophysiol. 1999 Mar;10(3):482-7. Review. No abstract available.

PMID:
10210516
7.

Value of a specific bradycardic agent in cardiac surgery compared to placebo.

Skarvan K.

Eur Heart J. 1987 Dec;8 Suppl L:123-9.

PMID:
3451878
9.

[Antiarrhythmic effect of iproveratril].

Fehér L, Kiss E, Vágfalvy I.

Z Gesamte Inn Med. 1971 Mar 15;26(6):202-4. German. No abstract available.

PMID:
5562202
10.

Arrhythmias and antiarrhythmic drugs.

Bigger JT Jr.

Adv Intern Med. 1972;18:251-81. Review. No abstract available.

PMID:
4576083
11.

[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].

Schipke JD, Büter I, Hohlfeld T, Schmitz-Spanke S, Gams E.

Herz. 2006 Feb;31(1):55-74. Review. German.

PMID:
16502273
12.

[Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].

Serdiuk EN, Koval'chuk LA.

Farmakol Toksikol. 1971;34(2):168-70. Russian. No abstract available.

PMID:
5563386
13.

[Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].

Filippova OV, Kryzhanovskiĭ SA, Peresada VP, Likhosherstov AM, Revenko SV, Kaverina NV, Reznikov KM.

Eksp Klin Farmakol. 2004 Jul-Aug;67(4):26-9. Russian.

PMID:
15500041
14.

[1st experiences with the clinical use of a new antiarrhythmic agent: bunaftide].

Lotto A, Lomanto B, Bossi M.

Cardiol Prat. 1972 Apr-Jun;23(2):123-33. Italian. No abstract available.

PMID:
5073277
15.

Alinidine in heart patients: electrophysiologic and antianginal actions.

Meinertz T, Kasper W, Jähnchen E.

Eur Heart J. 1987 Dec;8 Suppl L:109-14.

PMID:
3330524
16.
17.

[Combination therapy with anti-arrhythmia agents].

Lüderitz B, Jung W, Manz M.

Med Klin (Munich). 1992 Sep 15;87(9):465-8. Review. German. No abstract available.

PMID:
1406484
18.

Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Olsson SB, Brorson L, Varnauskas E.

Br Heart J. 1973 Dec;35(12):1255-9. No abstract available.

19.

[Action of propafenon in experimentally digitalis glycoside-induced arrhythmia].

Germiniani H, Branco Germiniani CD, Iark FB, do Pillar MD.

Arq Bras Cardiol. 1979 Jul;33(1):77-83. Portuguese. No abstract available.

PMID:
526179
20.

[Anti-arrhythmia agents. Effectiveness, lack of effectiveness and pro-arrhythmia effects].

Steinbeck G.

Internist (Berl). 1992 Oct;33(10):663-9. Review. German. No abstract available.

PMID:
1385349

Supplemental Content

Support Center